Abstract
Osteoporosis is a major public health concern, characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased susceptibility to fracture. Fracture repair progresses through different pathways, striking a balance between bone formation and bone remodeling mechanisms. Conventionally, fracture repair is divided into defined stages, each characterized by a specific set of cellular and molecular events. In postmenopausal women and elderly patients, bone healing rates are conditioned by cellular and molecular alterations to bone tissue that result in a progressive deterioration of fracture healing ability. In addition, in elderly patients, comorbidities and drugs therapies may also affect fracture healing. For this reason, pharmacological research is now focused on the possible use of antiosteoporotic drugs to promote bone healing in frail patients.
References
Schindeler A, McDonald MM, Bokko P, Little DG (2008) Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19:459–466
Jagodzinski M, Krettek C (2007) Effect of mechanical stability on fracture healing an update. Injury 38(Suppl 1):S3–S10
Giannoudis P, Tzioupis C, Almalki T, Buckley R (2007) Fracture-healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38(Suppl 1):S90–S99
Beil FT, Barvencik F, Gebauer M, Seitz S, Rueger JM, Ignatius A, Pogoda P, Schinke T, Amling M (2010) Effects of estrogen on fracture-healing in mice. J Trauma 69:1259–1265
Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V (2009) Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60:3356–3365
Lencel P, Magne D (2011) Inflammaging: the driving force in osteoporosis? Med Hypotheses 76:317–321
Montagnani A, Gonnelli S, Alessandri M, Nuti R (2011) Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res. 23:84–90
Bastos MF, Brilhante FV, Bezerra JP, Silva CA, Duarte PM (2010) Trabecular bone area and bone-healing in spontaneously hypertensive rats: a histometric study. Brazil Oral Res. 24:170–176
Tarantino U, Cerocchi I, Celi M, Scialdoni A, Saturnino L, Gasbarra E (2009) Pharmacological agents and bone-healing. Clin Cases Miner Bone Metab. 6:144–148
Goldhahn J, Féron JM, Kanis J, Papapoulos S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y, Boonen S (2012) Implications for fracture-healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int 90(5):343–353
Goldhahn J, Little D, Mitchell P, Fazzalari NL, Reid IR, Aspenberg P, Marsh D (2010) Evidence for anti-osteoporosis therapy in acute fracture situations Recommendations of a multidisciplinary workshop of the International Society for Fracture Repair. Bone 46:267–271
Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC (2010) Teriparatide for acceleration of fracture-repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25:404–414
Li YF, Luo E, Feng G, Zhu SS, Li JH, Hu J (2010) Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int 21:1889–1897
Habermann B, Kafchitsas K et al (2010) Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture-healing. Calcif Tissue Int 86:82–89
Maïmoun L, Brennan TC, Badoud I, Dubois-Ferriere V, Rizzoli R, Ammann P (2010) Strontium ranelate improves implant osseointegration. Bone 46(5):1436–1441
Li Y, Feng G, Gao Y, Luo E, Liu X, Hu J (2010) Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats. J Orthop Res 28(5):578–582
Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A (2011) Effects of anti-osteoporosis medications on fracture healing. Curr Osteoporos Rep 9:149–155
Brandi ML (2012) Drugs for bone healing. Expert Opin Investig Drugs 21:1169–1176
Alegre DN, Ribeiro C, Sousa C, Correia J, Silva L, de Almeida L (2012) Possible benefits of strontium ranelate in complicated long bone fractures. Rheumatol Int 32:439–443
Tarantino U, Celi M, Saturnino L, Scialdoni A, Cerocchi I (2010) Strontium ranelate and bone healing: report of two cases. Clin Cases Miner Bone Metab. 7:65–68
Conflict of interest
Authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarantino, U., Saturnino, L., Scialdoni, A. et al. Fracture healing in elderly patients: new challenges for antiosteoporotic drugs. Aging Clin Exp Res 25 (Suppl 1), 105–108 (2013). https://doi.org/10.1007/s40520-013-0096-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-013-0096-8